The authors reported increased spatial memory and habituation in APP transgenic mice treated with low doses of istradefylline (≤10 mg/kg/day) and underline the importance of further investigations of this adenosine receptor antagonist as potential therapeutic approach for AD or other neurodegenerative diseases besides PD [31]. The gene discussed is APP; the disease is Alzheimer disease.